Brief: Morphosys Announces U.S. Antitrust Clearance Of Proposed Acquisition By Novartis Under Hart-Scott-Rodino Act

Morphosys AG

22/03/2024 06:41

March 22 (Reuters) - MorphoSys AG  MORG.DE :
    * EQS-NEWS: MORPHOSYS ANNOUNCES U.S. ANTITRUST CLEARANCE OF
PROPOSED ACQUISITION BY NOVARTIS UNDER HART-SCOTT-RODINO ACT
    * MORPHOSYS AG - PROPOSED ACQUISITION OF MORPHOSYS BY
NOVARTIS HAS
NOW RECEIVED ALL MANDATORY REGULATORY APPROVALS
    * MORPHOSYS AG - MORPHOSYS AND NOVARTIS CONTINUE TO EXPECT
CLOSING
OF TAKEOVER OFFER TO TAKE PLACE IN FIRST HALF OF 2024
    * MORPHOSYS AG - TAKEOVER OFFER WILL REQUIRE A MINIMUM
ACCEPTANCE
THRESHOLD OF 65% OF MORPHOSYS' SHARE CAPITAL, AMONG OTHER
CUSTOMARY CLOSING CONDITIONS

Source text for Eikon:  ID:nEQ9xMWfFa 
Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))